{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:28:33Z","timestamp":1783456113918,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T00:00:00Z","timestamp":1244160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T00:00:00Z","timestamp":1244160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1038\/cgt.2009.39","type":"journal-article","created":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T13:09:50Z","timestamp":1244207390000},"page":"900-911","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy"],"prefix":"10.1038","volume":"16","author":[{"given":"D","family":"Boczkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pruitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,5]]},"reference":[{"key":"BFcgt200939_CR1","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm1100","volume":"10","author":"SA Rosenberg","year":"2004","unstructured":"Rosenberg SA, Yang JC, Restifo NP . Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004; 10: 909\u2013915.","journal-title":"Nat Med"},{"key":"BFcgt200939_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature06175","volume":"449","author":"RM Steinman","year":"2007","unstructured":"Steinman RM, Banchereau J . Taking dendritic cells into medicine. Nature 2007; 449: 419\u2013426.","journal-title":"Nature"},{"key":"BFcgt200939_CR3","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1172\/JCI31205","volume":"117","author":"E Gilboa","year":"2007","unstructured":"Gilboa E . DC-based cancer vaccines. J Clin Invest 2007; 117: 1195\u20131203.","journal-title":"J Clin Invest"},{"key":"BFcgt200939_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev.immunol.18.1.245","volume":"18","author":"L Fong","year":"2000","unstructured":"Fong L, Engleman EG . Dendritic cells in cancer immunotherapy. Annu Rev Immunol 2000; 18: 245\u2013273.","journal-title":"Annu Rev Immunol"},{"key":"BFcgt200939_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","volume":"212","author":"S Sakaguchi","year":"2006","unstructured":"Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8\u201327.","journal-title":"Immunol Rev"},{"key":"BFcgt200939_CR6","doi-asserted-by":"publisher","first-page":"8226","DOI":"10.1158\/1078-0432.CCR-05-2035","volume":"11","author":"G Dranoff","year":"2005","unstructured":"Dranoff G . The therapeutic implications of intratumoral regulatory T cells. Clin Cancer Res 2005; 11: 8226\u20138229.","journal-title":"Clin Cancer Res"},{"key":"BFcgt200939_CR7","first-page":"287","volume":"293","author":"T Nomura","year":"2005","unstructured":"Nomura T, Sakaguchi S . Naturally arising CD25+CD4+ regulatory T cells in tumor immunity. Curr Top Microbiol Immunol 2005; 293: 287\u2013302.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFcgt200939_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.20060214","volume":"203","author":"AY Rudensky","year":"2006","unstructured":"Rudensky AY, Campbell DJ . In vivo sites and cellular mechanisms of T reg cell-mediated suppression. J Exp Med 2006; 203: 489\u2013492.","journal-title":"J Exp Med"},{"key":"BFcgt200939_CR9","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942\u2013949.","journal-title":"Nat Med"},{"key":"BFcgt200939_CR10","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1158\/0008-5472.CAN-05-3773","volume":"66","author":"PE Fecci","year":"2006","unstructured":"Fecci PE, Mitchell DA, Whitesides JF, Xie W, Friedman AH, Archer GE et al. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res 2006; 66: 3294\u20133302.","journal-title":"Cancer Res"},{"key":"BFcgt200939_CR11","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.4049\/jimmunol.168.9.4272","volume":"168","author":"EY Woo","year":"2002","unstructured":"Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL et al. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002; 168: 4272\u20134276.","journal-title":"J Immunol"},{"key":"BFcgt200939_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1182\/blood-2005-07-2737","volume":"107","author":"G Zhou","year":"2006","unstructured":"Zhou G, Drake CG, Levitsky HI . Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood 2006; 107: 628\u2013636.","journal-title":"Blood"},{"key":"BFcgt200939_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrc2051","volume":"7","author":"I Melero","year":"2007","unstructured":"Melero I, Hervas-Stubbs S, Glennie M, Pardoll DM, Chen L . Immunostimulatory monoclonal antibodies for cancer therapy. Nat Rev Cancer 2007; 7: 95\u2013106.","journal-title":"Nat Rev Cancer"},{"key":"BFcgt200939_CR14","first-page":"5454","volume":"9","author":"O Murillo","year":"2003","unstructured":"Murillo O, Arina A, Tirapu I, Alfaro C, Mazzolini G, Palencia B et al. Potentiation of therapeutic immune responses against malignancies with monoclonal antibodies. Clin Cancer Res 2003; 9: 5454\u20135464.","journal-title":"Clin Cancer Res"},{"key":"BFcgt200939_CR15","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1073\/pnas.0830997100","volume":"100","author":"FS Hodi","year":"2003","unstructured":"Hodi FS, Mihm MC, Soiffer RJ, Haluska FG, Butler M, Seiden MV et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA 2003; 100: 4712\u20134717.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt200939_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/01.cji.0000208259.73167.58","volume":"29","author":"AV Maker","year":"2006","unstructured":"Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE et al. Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J Immunother 2006; 29: 455\u2013463.","journal-title":"J Immunother"},{"key":"BFcgt200939_CR17","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.1073\/pnas.1533209100","volume":"100","author":"GQ Phan","year":"2003","unstructured":"Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 2003; 100: 8372\u20138377.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt200939_CR18","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1158\/1078-0432.CCR-06-2318","volume":"13","author":"EJ Small","year":"2007","unstructured":"Small EJ, Tchekmedyian NS, Rini BI, Fong L, Lowy I, Allison JP . A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer. Clin Cancer Res 2007; 13: 1810\u20131815.","journal-title":"Clin Cancer Res"},{"key":"BFcgt200939_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/07357900701522315","volume":"25","author":"LD Cranmer","year":"2007","unstructured":"Cranmer LD, Hersh E . The role of the CTLA4 blockade in the treatment of malignant melanoma. Cancer Invest 2007; 25: 613\u2013631.","journal-title":"Cancer Invest"},{"key":"BFcgt200939_CR20","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa063842","volume":"355","author":"G Suntharalingam","year":"2006","unstructured":"Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD . Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006; 355: 1018\u20131028.","journal-title":"N Engl J Med"},{"key":"BFcgt200939_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/35101072","volume":"1","author":"P Carter","year":"2001","unstructured":"Carter P . Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001; 1: 118\u2013129.","journal-title":"Nat Rev Cancer"},{"key":"BFcgt200939_CR22","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1158\/0008-5472.CAN-05-2813","volume":"66","author":"AD Cohen","year":"2006","unstructured":"Cohen AD, Diab A, Perales MA, Wolchok JD, Rizzuto G, Merghoub T et al. Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity. Cancer Res 2006; 66: 4904\u20134912.","journal-title":"Cancer Res"},{"key":"BFcgt200939_CR23","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.4049\/jimmunol.172.12.7306","volume":"172","author":"F Kanamaru","year":"2004","unstructured":"Kanamaru F, Youngnak P, Hashiguchi M, Nishioka T, Takahashi T, Sakaguchi S et al. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J Immunol 2004; 172: 7306\u20137314.","journal-title":"J Immunol"},{"key":"BFcgt200939_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1084\/jem.20050940","volume":"202","author":"K Ko","year":"2005","unstructured":"Ko K, Yamazaki S, Nakamura K, Nishioka T, Hirota K, Yamaguchi T et al. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J Exp Med 2005; 202: 885\u2013891.","journal-title":"J Exp Med"},{"key":"BFcgt200939_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/emm.2005.26","volume":"37","author":"S La","year":"2005","unstructured":"La S, Kim E, Kwon B . In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Exp Mol Med 2005; 37: 193\u2013198.","journal-title":"Exp Mol Med"},{"key":"BFcgt200939_CR26","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.4049\/jimmunol.176.11.6434","volume":"176","author":"T Ramirez-Montagut","year":"2006","unstructured":"Ramirez-Montagut T, Chow A, Hirschhorn-Cymerman D, Terwey TH, Kochman AA, Lu S et al. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance\/ignorance to melanoma differentiation antigens and enhances antitumor immunity. J Immunol 2006; 176: 6434\u20136442.","journal-title":"J Immunol"},{"key":"BFcgt200939_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ni759","volume":"3","author":"J Shimizu","year":"2002","unstructured":"Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S . Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3: 135\u2013142.","journal-title":"Nat Immunol"},{"key":"BFcgt200939_CR28","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.4049\/jimmunol.179.11.7365","volume":"179","author":"P Zhou","year":"2007","unstructured":"Zhou P, L'Italien L, Hodges D, Schebye XM . Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors. J Immunol 2007; 179: 7365\u20137375.","journal-title":"J Immunol"},{"key":"BFcgt200939_CR29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nri1867","volume":"6","author":"EM Shevach","year":"2006","unstructured":"Shevach EM, Stephens GL . The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 2006; 6: 613\u2013618.","journal-title":"Nat Rev Immunol"},{"key":"BFcgt200939_CR30","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/eji.200425818","volume":"35","author":"G Nocentini","year":"2005","unstructured":"Nocentini G, Riccardi C . GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 2005; 35: 1016\u20131022.","journal-title":"Eur J Immunol"},{"key":"BFcgt200939_CR31","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1073\/pnas.94.12.6216","volume":"94","author":"G Nocentini","year":"1997","unstructured":"Nocentini G, Giunchi L, Ronchetti S, Krausz LT, Bartoli A, Moraca R et al. A new member of the tumor necrosis factor\/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA 1997; 94: 6216\u20136221.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt200939_CR32","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.4049\/jimmunol.173.8.5008","volume":"173","author":"GL Stephens","year":"2004","unstructured":"Stephens GL, McHugh RS, Whitters MJ, Young DA, Luxenberg D, Carreno BM et al. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 2004; 173: 5008\u20135020.","journal-title":"J Immunol"},{"key":"BFcgt200939_CR33","doi-asserted-by":"publisher","first-page":"15059","DOI":"10.1073\/pnas.2334901100","volume":"100","author":"M Tone","year":"2003","unstructured":"Tone M, Tone Y, Adams E, Yates SF, Frewin MR, Cobbold SP et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc Natl Acad Sci USA 2003; 100: 15059\u201315064.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt200939_CR34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1158\/0008-5472.CAN-06-2903","volume":"67","author":"S Nair","year":"2007","unstructured":"Nair S, Boczkowski D, Fassnacht M, Pisetsky D, Gilboa E . Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Res 2007; 67: 371\u2013380.","journal-title":"Cancer Res"},{"key":"BFcgt200939_CR35","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1182\/blood-2002-12-3738","volume":"102","author":"S Nair","year":"2003","unstructured":"Nair S, Boczkowski D, Moeller B, Dewhirst M, Vieweg J, Gilboa E . Synergy between tumor immunotherapy and antiangiogenic therapy. Blood 2003; 102: 964\u2013971.","journal-title":"Blood"},{"key":"BFcgt200939_CR36","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/79519","volume":"6","author":"SK Nair","year":"2000","unstructured":"Nair SK, Heiser A, Boczkowski D, Majumdar A, Naoe M, Lebkowski JS et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med 2000; 6: 1011\u20131017.","journal-title":"Nat Med"},{"key":"BFcgt200939_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2567.2008.02833.x","volume":"125","author":"J Lee","year":"2008","unstructured":"Lee J, Dollins CM, Boczkowski D, Sullenger BA, Nair S . Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses. Immunology 2008; 125: 229\u2013240.","journal-title":"Immunology"},{"key":"BFcgt200939_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1744-313X.1989.tb00475.x","volume":"16","author":"A Porgador","year":"1989","unstructured":"Porgador A, Feldman M, Eisenbach L . H-2\u2009Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence. J Immunogenet 1989; 16: 291\u2013303.","journal-title":"J Immunogenet"},{"key":"BFcgt200939_CR39","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1158\/0008-5472.CAN-07-5839","volume":"68","author":"H Nishikawa","year":"2008","unstructured":"Nishikawa H, Kato T, Hirayama M, Orito Y, Sato E, Harada N et al. Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling. Cancer Res 2008; 68: 5948\u20135954.","journal-title":"Cancer Res"},{"key":"BFcgt200939_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nm0402-343","volume":"8","author":"Z Ye","year":"2002","unstructured":"Ye Z, Hellstrom I, Hayden-Ledbetter M, Dahlin A, Ledbetter JA, Hellstrom KE . Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nat Med 2002; 8: 343\u2013348.","journal-title":"Nat Med"},{"key":"BFcgt200939_CR41","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00262-008-0451-3","volume":"57","author":"AD Simmons","year":"2008","unstructured":"Simmons AD, Moskalenko M, Creson J, Fang J, Yi S, VanRoey MJ et al. Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity. Cancer Immunol Immunother 2008; 57: 1263\u20131270.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcgt200939_CR42","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/sj.mt.6300310","volume":"15","author":"L Chen","year":"2007","unstructured":"Chen L, Huang TG, Meseck M, Mandeli J, Fallon J, Woo SL . Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation. Mol Ther 2007; 15: 2194\u20132202.","journal-title":"Mol Ther"},{"key":"BFcgt200939_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1158\/1078-0432.CCR-07-0940","volume":"14","author":"P Hu","year":"2008","unstructured":"Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H et al. Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer. Clin Cancer Res 2008; 14: 579\u2013588.","journal-title":"Clin Cancer Res"},{"key":"BFcgt200939_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1074-7613(02)00280-7","volume":"16","author":"RS McHugh","year":"2002","unstructured":"McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311\u2013323.","journal-title":"Immunity"},{"key":"BFcgt200939_CR45","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.4049\/jimmunol.176.9.5223","volume":"176","author":"J Kim","year":"2006","unstructured":"Kim J, Choi WS, Kang H, Kim HJ, Suh JH, Sakaguchi S et al. Conversion of alloantigen-specific CD8+ T cell anergy to CD8+ T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor. J Immunol 2006; 176: 5223\u20135231.","journal-title":"J Immunol"},{"key":"BFcgt200939_CR46","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.4049\/jimmunol.172.8.4686","volume":"172","author":"AP Kohm","year":"2004","unstructured":"Kohm AP, Williams JS, Miller SD . Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis. J Immunol 2004; 172: 4686\u20134690.","journal-title":"J Immunol"},{"key":"BFcgt200939_CR47","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/eji.200324804","volume":"34","author":"S Ronchetti","year":"2004","unstructured":"Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, Nocentini G et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 2004; 34: 613\u2013622.","journal-title":"Eur J Immunol"},{"key":"BFcgt200939_CR48","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1189\/jlb.0906568","volume":"82","author":"S Tuyaerts","year":"2007","unstructured":"Tuyaerts S, Van Meirvenne S, Bonehill A, Heirman C, Corthals J, Waldmann H et al. Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells. J Leukoc Biol 2007; 82: 93\u2013105.","journal-title":"J Leukoc Biol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt200939.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt200939","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt200939.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T11:39:54Z","timestamp":1647949194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt200939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,5]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["BFcgt200939"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2009.39","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,5]]},"assertion":[{"value":"25 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}